Narrative review reveals mixed health benefits of Juglans L. in human RCTs, highlighting the need for individual approaches.
Background: This review elucidates the multifaceted therapeutic effects of Juglans L. (J.), a medicinal plant with a rich heritage in traditional medicine and promising potential in modern healthcare. Methods: A narrative review was conducted focusing on randomized clinical trials (RCTs) published between 2000 and 2023. A comprehensive literature search was performed in databases including PubMed, Scopus, ClinicalKey, Google Scholar, and the Persian Scientific Information Database. The keywords “Juglans” and “J.” were used. Only human RCTs evaluating various parts of the plant (fruit, leaves, bark, internal septum) were included. Non-human and non-randomized studies were excluded. Results: The findings reveal that while some trials report significant health benefits of J., others show minimal or no effects, suggesting the importance of personalized approaches in clinical application. Conclusion: This review underscores the growing role of herbal medicine in preventive care and as a complement to standard treatments. Further studies are needed to clarify its mechanisms of action, determine optimal dosing, and evaluate long-term safety and efficacy. As global interest in natural remedies rises, J. stands out as a promising candidate in both preventive and therapeutic contexts.
No takes yet. Share an insight, caveat, or question.
Afra et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: